Therapeutic compounds for HIV viral infection
JP2024542543A5Active Publication Date: 2025-03-27GILEAD SCIENCES INC
0 Cites 0 Cited by
Patent Information
- Application Number
- JP2024531110
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-06-29
- Filing Date
- 2022-12-02
- Publication Date
- 2025-03-27
- Estimated Expiration
- 2042-12-02
AI Technical Summary
Technical Problem
Current HIV treatments require daily administration, and there is a need for less frequent dosing regimens to improve patient compliance and reduce the emergence of drug-resistant HIV strains.
Method used
Development of novel compounds, such as those described by Formula I, which can be administered less frequently (e.g., once every two days, once a week, or once a month) and are effective against drug-resistant HIV variants, offering enhanced pharmacokinetic properties.
Benefits of technology
These compounds provide a therapeutic benefit by reducing the frequency of dosing while maintaining efficacy against HIV, potentially slowing disease progression and addressing drug resistance.
✦ Generated by Eureka AI based on patent content.
Abstract
The present disclosure relates generally to certain compounds, pharmaceutical compositions containing the compounds, and methods of making and using the compounds and pharmaceutical compositions. The compounds and compositions provided herein can be used to treat or prevent retroviridae infections, including HIV infections.
Need to check novelty before this filing date? Find Prior Art